Directory
>
Robert Zeldin
Robert Zeldin
Chief Medical Officer | MeiraGTx
New York, New York, United States
Robert Zeldin
Summary
Robert Zeldin is a seasoned Chief Medical Officer with extensive experience in the biotechnology and pharmaceuticals sectors. He has held leadership roles in multiple organizations, including MeiraGTx, Immunovant, and Acceleron Pharma. His expertise spans clinical development, pharmacovigilance, and regulatory affairs, making him a pivotal figure in drug development and clinical research. Robert's career trajectory showcases a commitment to advancing medical science, particularly in oncology and immunology. He has a strong background in managing clinical trials and ensuring compliance with good clinical practices. Robert's work has had a significant impact on the development of innovative therapies, and he is well-regarded in the industry for his strategic insights. He holds an MD from Tufts University School of Medicine and a BA from Johns Hopkins University, reflecting a solid academic foundation. Robert is based in New York and is actively involved in the biotechnology community.
Robert Zeldin
Work Experience
Chief Medical Officer at
MeiraGTx
August 2020 - Present
Chief Medical Officer at
Immunovant
January 2019 - August 2020
Chief Medical Officer at
Acceleron Pharma
January 2018 - January 2019
Chief Medical Officer at
Ablynx
January 2015 - January 2018
Senior Vice President & Head - Global Clinical Development at
Stallergenes Greer
January 2011 - January 2015
Vice President & US Medical Franchise Head at
Novartis
January 2007 - January 2010
Executive Medical Director at
Novartis
January 2005 - January 2007
Senior Director - Clinical Development at
Merck
January 2004 - January 2005
Director - Clinical Development at
Merck
January 2000 - January 2004
Associate Director - Worldwide Regulatory Affairs at
Merck
January 1997 - January 2000
Director - Worldwide Regulatory Affairs at
Merck
January 2000 - January 2000
Medical Officer - Center for Biologics Evaluation and Research at
FDA
January 1996 - January 1997
Robert Zeldin
Education
Frequently Asked Questions about Robert Zeldin
What is Robert Zeldin email address?
Robert Zeldin's primary email address is *************@meiragtx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Robert Zeldin work for?
Robert Zeldin is a Chief Medical Officer at MeiraGTx, a company specializing in Commercial physical research.
Where Robert Zeldin graduated from?
Robert Zeldin holds a degree in from Johns Hopkins University.
How can I directly contact Robert Zeldin?
To contact Robert Zeldin directly, you can use the email address *************@meiragtx.com. Complete contact information is available upon registration with Muraena.
Who is Robert Zeldin?
Robert Zeldin is a seasoned Chief Medical Officer with extensive experience in the biotechnology and pharmaceuticals sectors. He has held leadership roles in multiple organizations, including MeiraGTx, Immunovant, and Acceleron Pharma. His expertise spans clinical development, pharmacovigilance, and regulatory affairs, making him a pivotal figure in drug development and clinical research. Robert's career trajectory showcases a commitment to advancing medical science, particularly in oncology and immunology. He has a strong background in managing clinical trials and ensuring compliance with good clinical practices. Robert's work has had a significant impact on the development of innovative therapies, and he is well-regarded in the industry for his strategic insights. He holds an MD from Tufts University School of Medicine and a BA from Johns Hopkins University, reflecting a solid academic foundation. Robert is based in New York and is actively involved in the biotechnology community.
Robert`s contact details
*************@meiragtx.com
*************@ablynx.com
Colleagues
Vice President Preclinical Development
VP MSAT
Chief Operating Officer
Vice President, Salivary Gland Therapeutics Lead
Executive Director, CMC Regulatory Affairs
Chief Executive Officer
VP, Biostatistics
VP Clinical Research and Ophthalmology
Senior Vice President, Head of Business Development